Pharmaceutical Intermediate Sofosbuvir Raw Material Sofosbuvir Powder Sofosbuvir

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Dsung-Sofosbuvir
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Sofosbuvir
• Name: Sofosbuvir Powder
• Appearance: White Crystalline Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Intermediate
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 1190307-88-0
• Mf: C22h29fn3o9p
• MW: 529.45300
• Einecs No.: 11-000-0
• Density: 1.41
• Melting Point: 120-125 C
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 500kg/Month

Product Description

Pharmaceutical Intermediate Sofosbuvir Raw Material Sofosbuvir Powder Sofosbuvir

 

Product Description

Product Details

Product Name	Sofosbuvir
CAS No.	1190307-88-0
MF	C22H29FN3O9P
MW	529.45300
Appearance and shape	White crystalline powder

Sofosbuvir is a new drug candidate for hepatitis C treatment, Previously known as PS-7977 or GS-7977, it has shown promising results in numerous in vitro studies against all the genotypes of HCV. It is a nucleotide analog that is a highly potent inhibitor of the NS5B polymerase in HCV. This drug has shown high efficacy in combination with several other drugs with and without PEG-INF, against HCV. Sofosbuvir is of special interest among the directly acting antiviral drugs under development, due to its high potency, low side effects, oral administration, and high barrier to resistance.

Application & Function

Funcation
1. Sofosbuvir is a kind of hepatitis c virus (HCV) NS5B polymerase inhibitors nucleotide analogues, applicable to as united antiviral treatment composition in the treatment of chronic hepatitis c (CHC) infection.
2. Sofosbuvir confirmed by test can effectively treat genotype 1, 2, 3, or 4 c subjects, including within milan criteria are awaiting liver transplantation of HCC subjects and co-infection of HCV/HIV - 1 subjects.
Application
Sofosbuvir is used in combination therapy with other antiviral medications to treat chronic hepatitis C virus (HCV) infected patients with HCV genoptypes 1-6, and to treat HCV and HIV co-infected patients.

Specification